Cellyan Biotechnology Co Ltd

HKPD

Company Profile

  • Business description

    Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

  • Contact

    13 Ko Fai Road
    Room B1, 5th Floor, Well Town Industrial Building
    Yau Tong
    Kowloon
    Hong Kong
    HKG

    T: +852 26189289

    http://www.9zt.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 March 2027

    Employees

    27

Stocks News & Analysis

stocks

Sales shine but broader macro outlook darkens for this ASX share

US stores are struggling, but our investment thesis hinges on the Australian rollout.
stocks

Chart of the Week: US equity market trading at an attractive discount

The latest from our Chief US Market Strategist.
stocks

Undervalued ASX share retains wide moat rating despite regulatory pressures

Proposed price regulation impacts our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,168.9043.800.48%
CAC 408,245.8018.07-0.22%
DAX 4023,806.99273.64-1.14%
Dow JONES (US)48,185.80275.880.58%
FTSE 10010,603.485.40-0.05%
HKSE25,752.40140.62-0.54%
NASDAQ22,822.42187.420.83%
Nikkei 22555,895.32413.10-0.73%
NZX 50 Index13,283.609.790.07%
S&P 5006,824.6641.850.62%
S&P/ASX 2008,973.2057.800.65%
SSE Composite Index3,966.1728.83-0.72%

Market Movers